This is a StreetInsider.com Premium Only Page

(SRRA) – StreetInsider.com Reports

Jul 18, 2022 04:07 PM Codexis (CDXS) Announces CEO Transition Effective August 9

Jun 17, 2022 07:02 AM Sierra Oncology (SRRA) Announces Submission of New Drug Application for Momelotinib to US Food & Drug Administration

Jun 2, 2022 08:59 AM Sierra Oncology (SRRA) Said HSR Waiting Period Expired Related to GSK Merger

Apr 14, 2022 03:50 AM Oppenheimer Downgrades Sierra Oncology Inc (SRRA) to Perform

Apr 14, 2022 03:50 AM Jefferies Downgrades Sierra Oncology Inc (SRRA) to Hold

Apr 13, 2022 09:40 AM H.C. Wainwright Downgrades Sierra Oncology Inc (SRRA) to Neutral Following Takeover

Apr 13, 2022 09:15 AM Pre-Open Stock Movers 04/13: (ATRS) (SRRA) (STAB) Higher; (NSTG) (LQDA) (BBBY) Lower (more...)

Apr 13, 2022 05:32 AM Sierra Oncology (SRRA) Acquired by GlaxoSmithKline (GSK) for $55/sh or $1.9B

Mar 14, 2022 06:34 AM Sierra Oncology Inc (SRRA) PT Raised to $45 at Oppenheimer

Feb 1, 2022 05:09 PM Sierra Oncology (SRRA) Director Sinclair Buys 150K Shares

Jan 31, 2022 06:25 AM Sierra's (SRRA) momelotinib Peak Sales Projected at $1.7B - H. C. Wainwright

Jan 31, 2022 06:08 AM Sierra Oncology Inc (SRRA) PT Raised to $51 at H.C. Wainwright

Jan 27, 2022 05:50 AM Sierra Oncology (SRRA) Prices Upsized 4.07M Share Offering at $27/sh

Jan 26, 2022 04:10 PM Sierra Oncology Inc (SRRA) PT Raised to $38 at Oppenheimer, Following Clinical Business Update

Jan 26, 2022 11:49 AM Sierra Oncology (SRRA) Adds to Yesterday's Gain, Up 18%

Jan 25, 2022 04:01 PM Sierra Oncology (SRRA) Announces $100M Stock Offering

Jan 25, 2022 09:43 AM Sierra Oncology (SRRA) Halted on Volatility, Up 64%

Jan 25, 2022 07:19 AM Sierra Oncology (SRRA) to Resume Trading at 7:30 a.m.

Jan 25, 2022 07:19 AM Sierra Oncology (SRRA) Provides Financial Update to Support the Future Commercialization of Momelotinib

Jan 25, 2022 07:01 AM Sierra Oncology (SRRA) Announces Momelotinib Achieved Statistically Significant Benefit on Symptoms, Anemia and Splenic Size in the Pivotal MOMENTUM Study for Myelofibrosis

Jan 25, 2022 06:55 AM Sierra Oncology (SRRA) Halted, News Pending

Jan 19, 2022 05:43 AM Sierra Oncology Inc (SRRA) PT Raised to $32 at Oppenheimer

Jan 18, 2022 07:02 AM Sierra Oncology (SRRA) Expects Pivotal Phase 3 Momelotinib Data Sooner Than Planned

Dec 14, 2021 05:53 AM Sierra Oncology (SRRA) Announces Baseline Ferritin Differentially Predicts Week 24 Transfusion Independence Response in Myelofibrosis Patients

Nov 10, 2021 04:56 PM ORIC Pharmaceuticals (ORIC) Appoints Angie You, Ph.D., to its Board of Directors

Nov 5, 2021 10:46 AM UPDATE: Sierra Oncology Inc (SRRA) PT Raised to $35 at H.C. Wainwright, Following Earnings

Nov 5, 2021 08:04 AM Sierra Oncology (SRRA) Files $200M Mixed Shelf

Sep 27, 2021 06:41 AM Cantor Fitzgerald Starts Sierra Oncology Inc (SRRA) at Overweight

Aug 9, 2021 07:22 AM Sierra Oncology (SRRA) Provides Update to Momelotinib Development Timeline and Closes on $34 Million in Additional Funding

Jun 22, 2021 06:47 AM Sierra Oncology Inc (SRRA) KOL Panel Highlights Momelotinib’s Efficacy - H.C. Wainwright

May 12, 2021 10:05 AM Sierra Oncology (SRRA) Announces Oral Presentation at European Hematology Association Annual Meeting

Dec 11, 2020 06:11 AM H.C. Wainwright Assumes Sierra Oncology Inc (SRRA) at Buy

Dec 7, 2020 10:07 AM Sierra Oncology (SRRA) Announces Momelotinib Data for Intermediate / High-risk Myelofibrosis Patients with Lower Baseline Platelet Counts

Nov 10, 2020 07:07 AM Sierra Oncology Inc (SRRA) PT Lowered to $27 at Oppenheimer

Aug 10, 2020 04:32 AM Sierra Oncology Inc (SRRA) PT Raised to $17 at Jefferies

Jul 30, 2020 06:31 AM UPDATE: H.C. Wainwright Starts Sierra Oncology Inc (SRRA) at Buy

Jun 12, 2020 06:22 AM Sierra Oncology (SRRA) Presents Favorable Long-Term Safety and Dose Intensity Data for Momelotinib at EHA25 2020 Virtual Meetings

May 26, 2020 07:02 AM Sierra Oncology (SRRA) Appoints Dr. Stephen Dilly as President and CEO

Jan 28, 2020 02:17 PM Sierra Oncology Inc (SRRA) PT Raised to $48 at Oppenheimer, Following Reverse SPlit

Jan 22, 2020 07:03 AM Sierra Oncology (SRRA) Announces Reverse Stock Split at Ratio of 1-for-40

Dec 5, 2019 04:06 PM Oppenheimer Starts Sierra Oncology Inc (SRRA) at Outperform

Nov 20, 2019 07:09 AM Sierra Oncology (SRRA) Reports Launch of MOMENTUM Phase 3 Clinical Trial for Patients with Myelofibrosis

Nov 7, 2019 09:15 AM Sierra Oncology (SRRA) Announces Pricing of $103 Million Public Offering of Convertible Preferred Stock and Warrants

Nov 6, 2019 05:26 PM Sierra Oncology (SRRA) Announces Proposed Public Offering of Convertible Preferred Stock and Warrants

Aug 12, 2019 07:52 AM Sierra Oncology Inc (SRRA) PT Raised to $3 at SunTrust

Jun 27, 2019 07:07 AM Sierra Oncology (SRRA) Launches Campaign Exploring Non-Dilutive Strategic Options to Support Development of its DDR Assets

Jun 5, 2019 06:02 AM Sierra Oncology (SRRA) Reports Momelotinib Granted FDA Fast Track Designation

Jun 4, 2019 05:08 PM Sierra Oncology (SRRA) Announces FDA Regulatory Clarity for Momelotinib & Design of MOMENTUM Phase 3 Clinical Trial

Apr 1, 2019 04:07 PM Sierra Oncology (SRRA) Reports Late-Breaking Preclinical Data for SRA737 Presented at AACR

Dec 3, 2018 07:06 AM Sierra Oncology (SRRA) Announces Robust Transfusion Independence Rates in Transfusion Dependent Myelofibrosis Patients Treated with Momelotinib